New controversies and new directions.
Ambinder
R F
RF
D019380:Anti-HIV Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007167:Immunotherapy; D016483:Lymphoma, AIDS-Related / Q000473:pathology / Q000628:therapy*; D012514:Sarcoma, Kaposi / Q000473:pathology / Q000628:therapy*
D019380:Anti-HIV Agents